Clinical Trial Update: A Clinical Trial Using Metronomic Oral Low-dose Cyclophosphamide Alternating With Low-dose Oral Methotrexate With Continuous Celecoxib and Weekly Vinblastine in Children and Adolescents With Relapsed or Progressing soliD Tumours. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating metronomic cyclophosphamide alternating with methotrexate, continuous celecoxib, and weekly vinblastine in pediatric solid tum…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Celecoxib (Celecoxib)
• METHOTREXATE (METHOTREXATE)
• Vinblastine (vinblastine)

Snippet

Sponsor: Assistance Publique Hopitaux De Marseille | Conditions: Survival Without Progression | Phase 2 | Status: COMPLETED